# BCP Investment Corp: overview BCIC · Nasdaq · CIK 1372807 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bcic.md) · [Financials](/companies/bcic/financials.md) · [Filings](/companies/bcic/filings.md) · [Insiders](/companies/bcic/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.16)](/filings/0001193125-25-269482.md) | [(0.28)](/filings/0000950170-25-038754.md) | [(0.01)](/filings/0001193125-26-211878.md) | [(0.49)](/filings/0001193125-26-337959.md) | [1.86](/filings/0001193125-25-269482.md) | not reported | [(0.82)](/filings/0001193125-26-211878.md) | [(0.80)](/filings/0001193125-26-337959.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [3.05](/filings/0000950170-24-030788.md) | [(2.18)](/filings/0000950170-25-038754.md) | [1.20](/filings/0001193125-26-093918.md) | [(0.64)](/filings/0001193125-26-093918.md) | [1.04](/filings/0001193125-26-093918.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bcic/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Bulldog Investors, LLP](/funds/1504304.md) | 2026-06-30 | $2.8m | 378,412 | | Unchanged | | [JB CAPITAL PARTNERS LP](/funds/1138532.md) | 2026-06-30 | $1.4m | 197,036 | | Added +29,589 | | [WEALTH ENHANCEMENT ADVISORY SERVICES, LLC](/funds/1632972.md) | 2026-06-30 | $1.2m | 157,910 | | Added +71,157 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $719.8k | 98,879 | | Added +29,218 | | [RAYMOND JAMES FINANCIAL INC](/funds/720005.md) | 2026-06-30 | $687.9k | 94,495 | | Reduced −10,922 | | [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $683.5k | 93,881 | | Unchanged | | [Founders Financial Alliance, LLC](/funds/1832190.md) | 2026-06-30 | $587.5k | 80,706 | | Reduced −2,311 | | [Curi Capital, LLC](/funds/1332905.md) | 2026-06-30 | $473.2k | 65,000 | | Added +27,200 | | [GABLES CAPITAL MANAGEMENT INC.](/funds/1740839.md) | 2026-06-30 | $338.7k | 46,531 | | Reduced −540 | | [Triumph Capital Management](/funds/1730765.md) | 2026-06-30 | $302.6k | 41,562 | | New +41,562 | ## Recent filings [All 859 filings](/companies/bcic/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-03 | 16:05 ET | [8-K](/filings/0001193125-26-381876.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-381876 | | 2026-08-12 | 12:27 ET | [8-K](/filings/0001193125-26-346267.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-346267 | | 2026-08-07 | 16:15 ET | [8-K](/filings/0001193125-26-340277.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-340277 | | 2026-08-06 | 16:06 ET | [10-Q](/filings/0001193125-26-337959.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337959 | | 2026-06-26 | 16:11 ET | [8-K](/filings/0001193125-26-285488.md) | 5.07 Shareholder vote results | 0001193125-26-285488 | | 2026-05-08 | 17:23 ET | [8-K](/filings/0001193125-26-215068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-215068 | | 2026-05-07 | 16:07 ET | [10-Q](/filings/0001193125-26-211878.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211878 | | 2026-04-29 | 16:38 ET | [DEF 14A](/filings/0001193125-26-191971.md) | Proxy statement, period 2026-06-25 | 0001193125-26-191971 | | 2026-03-24 | 17:18 ET | [8-K](/filings/0001193125-26-122220.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-122220 | | 2026-03-12 | 16:12 ET | [8-K](/filings/0001193125-26-104166.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-104166 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-093918.md), filed Mar 5, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1372807 - Tickers: BCIC - Exchange: Nasdaq - SIC code: not reported - State of incorporation: DE - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.